Read More: eGenesis Announces World’s First Successful Transplant of Genetically Engineered Porcine Kidney in a Living Patient


Albert (Al) Wiegman

Board Director

With nearly 20 years of experience in venture capital, Mr. Wiegman has a profound understanding of how challenging it is for entrepreneurs to create and build successful companies, and how vital it is to choose the right partner and investor to grow their businesses and achieve their goals.

During his tenure, he has generated a successful track record across the technology and healthcare sectors. Directly participated in 30 early-stage venture investments in software, healthcare IT, medical devices and healthcare services. A hands-on board member, passionate about investment and value-creation processes combined with a unique blend of strategic and operational expertise. Mr. Wiegman is adept at actively assisting portfolio companies to formulate corporate strategies to facilitate growth, financings and exit opportunities.

Al Wiegman